Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Gainers
IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
Autoimmune Biotech Scores $26M Payment, Up To $139M To Advance Phase 3 Research
Equillium Inc (NASDAQ:EQ) announced an option and asset purchase agreement through which Ono Pharmaceutical Co Ltd gains the exclusive option to purchase Equillium’s…
Ocular Therapeutix And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones dipped by more than 600 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
Equillium Inc (NASDAQ:EQ) has agreed to acquire Metacrine Inc (NASDAQ:MTCR) in an all-stock transaction. The transaction is anticipated to add $33 million…